Navigation Links
Jennerex Announces First Patient Treated in Phase 2a Clinical Trial of JX-594 as a Neoadjuvant Therapy in Colorectal Cancer Patients Undergoing Surgery
Date:12/21/2011

ts cancer cells due to common genetic defects in cancer cells. JX-594 was engineered to enhance this natural safety and cancer-selectivity by deleting its thymidine kinase (TK) gene, thus making it dependent on the cellular TK expressed at persistently high levels in cancer cells. To enhance product efficacy, JX-594 is also engineered to express the immunogenic GM-CSF protein. GM-CSF complements the cancer cell lysis of the product candidate, leading to a cascade of events resulting in tumor necrosis, tumor vasculature shutdown and sustained anti-tumoral immune attack.

About Colorectal Cancer

Colorectal cancer is the second leading cause of cancer-related deaths in the United States and according to the World Health Organization, it accounts for approximately 639,000 deaths worldwide each year. Approximately one in 20 people in the United States will develop CRC during their lifetime, with the risk increasing with age. Ninety percent of all CRC cases are diagnosed in people over the age of 50. The exact cause of colorectal cancer is not known, although there are certain known risk factors that increase the chance of developing colorectal cancer. These risk factors include inflammatory bowel disease, family history of CRC, certain genetic syndromes, smoking, low fruit and vegetable intake and a sedentary lifestyle.

About Jennerex's Partners for JX-594

Transgene (NYSE Euronext Paris: FR0005175080), a bio-pharmaceutical company specialized in the development of immunotherapeutic products, holds an exclusive license to develop and commercialize JX-594 in Europe and neighboring countries. Green Cross Corporation, a leading company in the development, manufacturing, and commercialization of viral vaccines and other biological products, holds an exclusive license to develop and commercialize JX-594 in South Korea, and Lee's Pharmaceutical Ltd. holds an exclusive license to develop and commercialize JX-594 in China.

Tra
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
2. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
3. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
4. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
5. Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
6. Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
7. Jennerex, Inc. Receives EMEA Orphan Drug Designation for JX-594 for the Treatment of Hepatocellular Carcinoma
8. Jennerex Announces Presentations at Upcoming Conferences
9. Jennerex Appoints Gregory W. Schafer as Chief Financial Officer
10. Jennerex Appoints Lara Longpre to Chief Operating Officer
11. Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, ... and technologies must be able to protect ... (IP). (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ... nature of the Medical Device Industry, it ... industry sectors of cases involving IP infringement. ...
(Date:1/15/2014)... , Jan. 15, 2014 The ... as a Medical Fitness Center by the Medical ... health and fitness centers to achieve their full ... the only certified fitness center in the western ... "The certification means the Cadence Fitness & ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Delivery Systems -- Focus on End Users ... STUDY OBJECTIVES A drug delivery ... aspects in today,s growth in the pharmaceutical ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18
(Date:4/14/2014)... COLUMBUS, Ohio Heart patients with beliefs about health ... to skip sessions of cardiac rehabilitation, new research suggests. ... number of these beliefs referred to as "irrational ... was associated with lower adherence to a prescribed ... assessed: Doubting the preventive power of the flu vaccine ...
(Date:4/14/2014)... A new study shows that domestic abuse is ... depression and post-traumatic stress disorder (PTSD), in mothers. ... abuse are associated with specific mental health problems. ... Carolina State University, Simon Fraser University and the ... see whether and how intimate partner abuse ...
(Date:4/14/2014)... to treatment guidelines for high-risk bladder cancer, chemotherapy ... in routine clinical practice. The findings are published ... journal of the American Cancer Society. , Clinical ... patients with muscle-invasive bladder cancer who are given ... whether chemotherapy after surgery also improves survival. To ...
(Date:4/13/2014)... force has created a new definition for epilepsy that ... disease. The study published in Epilepsia , a ... League Against Epilepsy (ILAE), provides a greater level of ... unprovoked seizures, and those with one unprovoked seizure and ... , The 2005 report by the ILAE task force ...
(Date:4/11/2014)... there is still no effective medical treatment. In an ... of a schizophrenic person, researchers from the University of ... rats that have been given hallucinogenic drugs. This may ... Seven per cent of the adult population suffers from ... understand the disease, they still do not know what ...
Breaking Medicine News(10 mins):Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 2Health News:Irrational health beliefs linked to skipping cardiac rehab sessions 3Health News:Study links domestic abuse to mental health problems in new mothers 2Health News:New clinical definition for epilepsy improves diagnosis accuracy 2Health News:Protein researches closing in on the mystery of schizophrenia 2Health News:Protein researches closing in on the mystery of schizophrenia 3
... say , WEDNESDAY, Nov. 14 (HealthDay News) -- U.S. scientists ... in cancer cells. , They found that genes in cancer ... structures called nucleosomes within the cells. , "The study shows ... in cancer cells. It identifies what the target looks like, ...
... other partners and donors share in success, ... National,Pediatric Brain Tumor Consortium headquarters, Chili,s Care ... for exceptional patient care, MEMPHIS, Tenn., Nov. ... Grill & Bar(R) celebrated the national,grand opening of ...
... Toy Drive to Benefit Shands Jacksonville-Marks Grand Opening ... Bank will,officially dedicate its new Mandarin branch today ... will attend the,grand opening event this morning, which ... opening of the facility and the,Company,s expanded presence ...
... With half of dogs and cats over age 10 dying of cancer, ... free oncology consultations ... any pet., BOISE, Idaho, Nov. 14 When Jack Stephens, DVM, ... emotional support from his small dog, Spanky. Recognizing that,cancer now claims the ...
... Be Held in Conjunction with Inaugural Gala, NORTH ... the National Patient Safety Foundation today announced that it ... 7-8, 2008 in,Boston, Massachusetts. The Institute, established by NPSF ... strategic paths and calls to action for,the field of ...
... initials? Most people do and, as past research has shown, ... For example, Jack is more likely to move to Jacksonville ... to move to Philadelphia and marry Phyllis. Scientists call this ... enough to encourage the pursuit of name-resembling life outcomes and ...
Cached Medicine News:Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 3Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 4Health News:CapitalSouth Bank Officially Opens Three of Four New Locations in Jacksonville 2Health News:CapitalSouth Bank Officially Opens Three of Four New Locations in Jacksonville 3Health News:All Pets With Cancer in U.S. Provided Free Consultation 2Health News:All Pets With Cancer in U.S. Provided Free Consultation 3Health News:All Pets With Cancer in U.S. Provided Free Consultation 4Health News:Lucian Leape Institute Announces First Roundtable 2Health News:Lucian Leape Institute Announces First Roundtable 3Health News:What's in a name? Initials linked to success, study shows 2
... accommodate a variety of applications across a ... DestinyPlus is suitable for any laboratory demanding ... a mixed-mode throughput exceeding 95 PT/aPTT/Fibrinogen per ... full range of chromogenics, the AMAX DestinyPlus ...
Non-invasive and continuous tcpCO2 and tcpO2 patient monitoring....
Two separate sensors provide continuous measurement of tcpO2/tcpCO2 and SpO2....
... components that comprise the SmartPill GI ... comprise the SmartPill GI Monitoring System: ... Receiver software and SmartPill MotiliGI software. ... indispensable parts of the SmartPill GI ...
Medicine Products: